PLoS Negl Trop Dis. 2026 Mar 12;20(3):e0014022. doi: 10.1371/journal.pntd.0014022. eCollection 2026 Mar.
ABSTRACT
Chagas disease, a neglected tropical disease, is endemic in the Amazon region, where oral transmission predominates. Autonomic nervous system (ANS) impairment is a recognized pathophysiological mechanism contributing to disease progression, including Chagas cardiomyopathy. This study aimed to assess ANS function in patients with acute Chagas disease from the Amazon, evaluating responses pre- and post-benznidazole treatment. We included 28 acute-phase patients and 20 healthy controls. Participants underwent comprehensive cardiac evaluations, including 12-lead ECG, echocardiogram, 24-hour Holter monitoring, treadmill stress testing, and 5-minute heart rate variability (HRV) assessment. HRV was analyzed across time, frequency, and nonlinear domains, with statistical comparisons performed between groups and within the patient cohort. The study population predominantly comprised individuals from rural Amazonian municipalities (89.3%), with oral transmission accounting for 85.7% of infections. While resting ECGs were normal in 60.7%, diffuse ventricular repolarization was the most common abnormality (21.4%). Before treatment, 24-hour HRV showed significant reductions in SDANN and SDNN, indicating sympathovagal imbalance. For 5-minute HRV, significant alterations were observed across time (rMSSD, SDNN), frequency (LF, HF, LF/HF ratio), and nonlinear domains, reflecting reduced parasympathetic tone. Intragroup comparisons (pre- vs. post-treatment) further reinforced the sustained sympathovagal imbalance and parasympathetic inhibition. These findings highlight persistent autonomic modulation alterations, characterized by sympathovagal imbalance and reduced parasympathetic activity, in acute Chagas disease patients from the Amazon. Such dysfunction may predispose individuals to long-term structural cardiac changes and arrhythmias, underscoring the critical need for continued monitoring and potential targeted interventions to address autonomic imbalance in this vulnerable population.
PMID:41818258 | DOI:10.1371/journal.pntd.0014022